Thyroid cancer

Summary Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and women in 2015. The incidence continues to rise worldwide. Differentiated thyroid cancer is the most frequent subtype of thyroid cancer and in most patients the stand...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2016-12, Vol.388 (10061), p.2783-2795
Main Authors: Cabanillas, Maria E, Dr, McFadden, David G, MD, Durante, Cosimo, MD
Format: Article
Language:English
Subjects:
Carcinoma, Neuroendocrine - diagnosis
Carcinoma, Neuroendocrine - diagnostic imaging
Carcinoma, Neuroendocrine - surgery
Clinical trials
Diagnosis, Differential
Disease-Free Survival
Humans
Internal Medicine
Iodine
Iodine radioisotopes
Kinases
Metastasis
Mutation
Severity of Illness Index
Thyroid
Thyroid cancer
Thyroid Neoplasms - diagnosis
Thyroid Neoplasms - diagnostic imaging
Thyroid Neoplasms - genetics
Thyroid Neoplasms - physiopathology
Thyroid Neoplasms - surgery
Tumors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c547t-9856404f09559c57d3a7537aa8dcbdd48aa8aa5a692247d7b1ca66711ab74f3c3
cites cdi_FETCH-LOGICAL-c547t-9856404f09559c57d3a7537aa8dcbdd48aa8aa5a692247d7b1ca66711ab74f3c3
container_end_page 2795
container_issue 10061
container_start_page 2783
container_title The Lancet (British edition)
container_volume 388
creator Cabanillas, Maria E, Dr
McFadden, David G, MD
Durante, Cosimo, MD
description Summary Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and women in 2015. The incidence continues to rise worldwide. Differentiated thyroid cancer is the most frequent subtype of thyroid cancer and in most patients the standard treatment (surgery followed by either radioactive iodine or observation) is effective. Patients with other, more rare subtypes of thyroid cancer—medullary and anaplastic—are ideally treated by physicians with experience managing these malignancies. Targeted treatments that are approved for differentiated and medullary thyroid cancers have prolonged progression-free survival, but these drugs are not curative and therefore are reserved for patients with progressive or symptomatic disease.
doi_str_mv 10.1016/S0140-6736(16)30172-6
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1826692040</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0140673616301726</els_id><sourcerecordid>4272434411</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-9856404f09559c57d3a7537aa8dcbdd48aa8aa5a692247d7b1ca66711ab74f3c3</originalsourceid><addsrcrecordid>eNqFkE1LwzAYgIMobk79B4rgZR6qb9p89aLI8AsGHpzgLaRJipldq8kq7N-brXPCLp6SwPM-SR6ETjBcYsDs6gUwgYTxjA0xu8gA8zRhO6iPCScJJfxtF_U3SA8dhDAFAMKA7qNeylMCQtA-Op68L3zjzJlWtbb-EO2Vqgr2aL0O0Ov93WT0mIyfH55Gt-NER_U8yQVlBEgJOaW5ptxkitOMKyWMLowhIu6UoorlaUq44QXWijGOsSo4KTOdDdCw83765qu1YS5nLmhbVaq2TRskFimLw0Agoudb6LRpfR1fFynCRAYpFZGiHaV9E4K3pfz0bqb8QmKQy2ByFUwua8h4WgWTLM6dru1tMbNmM_VbKAI3HWBjjm9nvQza2djKOG_1XJrG_XvF9ZZBV652WlUfdmHD329kSCV0kqUDs5WBZT8a9ot1</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1846830258</pqid></control><display><type>article</type><title>Thyroid cancer</title><source>Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)</source><creator>Cabanillas, Maria E, Dr ; McFadden, David G, MD ; Durante, Cosimo, MD</creator><creatorcontrib>Cabanillas, Maria E, Dr ; McFadden, David G, MD ; Durante, Cosimo, MD</creatorcontrib><description>Summary Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and women in 2015. The incidence continues to rise worldwide. Differentiated thyroid cancer is the most frequent subtype of thyroid cancer and in most patients the standard treatment (surgery followed by either radioactive iodine or observation) is effective. Patients with other, more rare subtypes of thyroid cancer—medullary and anaplastic—are ideally treated by physicians with experience managing these malignancies. Targeted treatments that are approved for differentiated and medullary thyroid cancers have prolonged progression-free survival, but these drugs are not curative and therefore are reserved for patients with progressive or symptomatic disease.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(16)30172-6</identifier><identifier>PMID: 27240885</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Carcinoma, Neuroendocrine - diagnosis ; Carcinoma, Neuroendocrine - diagnostic imaging ; Carcinoma, Neuroendocrine - surgery ; Clinical trials ; Diagnosis, Differential ; Disease-Free Survival ; Humans ; Internal Medicine ; Iodine ; Iodine radioisotopes ; Kinases ; Metastasis ; Mutation ; Severity of Illness Index ; Thyroid ; Thyroid cancer ; Thyroid Neoplasms - diagnosis ; Thyroid Neoplasms - diagnostic imaging ; Thyroid Neoplasms - genetics ; Thyroid Neoplasms - physiopathology ; Thyroid Neoplasms - surgery ; Tumors</subject><ispartof>The Lancet (British edition), 2016-12, Vol.388 (10061), p.2783-2795</ispartof><rights>Elsevier Ltd</rights><rights>2016 Elsevier Ltd</rights><rights>Copyright © 2016 Elsevier Ltd. All rights reserved.</rights><rights>Copyright Elsevier Limited Dec 3, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-9856404f09559c57d3a7537aa8dcbdd48aa8aa5a692247d7b1ca66711ab74f3c3</citedby><cites>FETCH-LOGICAL-c547t-9856404f09559c57d3a7537aa8dcbdd48aa8aa5a692247d7b1ca66711ab74f3c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27240885$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cabanillas, Maria E, Dr</creatorcontrib><creatorcontrib>McFadden, David G, MD</creatorcontrib><creatorcontrib>Durante, Cosimo, MD</creatorcontrib><title>Thyroid cancer</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Summary Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and women in 2015. The incidence continues to rise worldwide. Differentiated thyroid cancer is the most frequent subtype of thyroid cancer and in most patients the standard treatment (surgery followed by either radioactive iodine or observation) is effective. Patients with other, more rare subtypes of thyroid cancer—medullary and anaplastic—are ideally treated by physicians with experience managing these malignancies. Targeted treatments that are approved for differentiated and medullary thyroid cancers have prolonged progression-free survival, but these drugs are not curative and therefore are reserved for patients with progressive or symptomatic disease.</description><subject>Carcinoma, Neuroendocrine - diagnosis</subject><subject>Carcinoma, Neuroendocrine - diagnostic imaging</subject><subject>Carcinoma, Neuroendocrine - surgery</subject><subject>Clinical trials</subject><subject>Diagnosis, Differential</subject><subject>Disease-Free Survival</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Iodine</subject><subject>Iodine radioisotopes</subject><subject>Kinases</subject><subject>Metastasis</subject><subject>Mutation</subject><subject>Severity of Illness Index</subject><subject>Thyroid</subject><subject>Thyroid cancer</subject><subject>Thyroid Neoplasms - diagnosis</subject><subject>Thyroid Neoplasms - diagnostic imaging</subject><subject>Thyroid Neoplasms - genetics</subject><subject>Thyroid Neoplasms - physiopathology</subject><subject>Thyroid Neoplasms - surgery</subject><subject>Tumors</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LwzAYgIMobk79B4rgZR6qb9p89aLI8AsGHpzgLaRJipldq8kq7N-brXPCLp6SwPM-SR6ETjBcYsDs6gUwgYTxjA0xu8gA8zRhO6iPCScJJfxtF_U3SA8dhDAFAMKA7qNeylMCQtA-Op68L3zjzJlWtbb-EO2Vqgr2aL0O0Ov93WT0mIyfH55Gt-NER_U8yQVlBEgJOaW5ptxkitOMKyWMLowhIu6UoorlaUq44QXWijGOsSo4KTOdDdCw83765qu1YS5nLmhbVaq2TRskFimLw0Agoudb6LRpfR1fFynCRAYpFZGiHaV9E4K3pfz0bqb8QmKQy2ByFUwua8h4WgWTLM6dru1tMbNmM_VbKAI3HWBjjm9nvQza2djKOG_1XJrG_XvF9ZZBV652WlUfdmHD329kSCV0kqUDs5WBZT8a9ot1</recordid><startdate>20161203</startdate><enddate>20161203</enddate><creator>Cabanillas, Maria E, Dr</creator><creator>McFadden, David G, MD</creator><creator>Durante, Cosimo, MD</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20161203</creationdate><title>Thyroid cancer</title><author>Cabanillas, Maria E, Dr ; McFadden, David G, MD ; Durante, Cosimo, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-9856404f09559c57d3a7537aa8dcbdd48aa8aa5a692247d7b1ca66711ab74f3c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Carcinoma, Neuroendocrine - diagnosis</topic><topic>Carcinoma, Neuroendocrine - diagnostic imaging</topic><topic>Carcinoma, Neuroendocrine - surgery</topic><topic>Clinical trials</topic><topic>Diagnosis, Differential</topic><topic>Disease-Free Survival</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Iodine</topic><topic>Iodine radioisotopes</topic><topic>Kinases</topic><topic>Metastasis</topic><topic>Mutation</topic><topic>Severity of Illness Index</topic><topic>Thyroid</topic><topic>Thyroid cancer</topic><topic>Thyroid Neoplasms - diagnosis</topic><topic>Thyroid Neoplasms - diagnostic imaging</topic><topic>Thyroid Neoplasms - genetics</topic><topic>Thyroid Neoplasms - physiopathology</topic><topic>Thyroid Neoplasms - surgery</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cabanillas, Maria E, Dr</creatorcontrib><creatorcontrib>McFadden, David G, MD</creatorcontrib><creatorcontrib>Durante, Cosimo, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cabanillas, Maria E, Dr</au><au>McFadden, David G, MD</au><au>Durante, Cosimo, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Thyroid cancer</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2016-12-03</date><risdate>2016</risdate><volume>388</volume><issue>10061</issue><spage>2783</spage><epage>2795</epage><pages>2783-2795</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Summary Thyroid cancer is the fifth most common cancer in women in the USA, and an estimated over 62 000 new cases occurred in men and women in 2015. The incidence continues to rise worldwide. Differentiated thyroid cancer is the most frequent subtype of thyroid cancer and in most patients the standard treatment (surgery followed by either radioactive iodine or observation) is effective. Patients with other, more rare subtypes of thyroid cancer—medullary and anaplastic—are ideally treated by physicians with experience managing these malignancies. Targeted treatments that are approved for differentiated and medullary thyroid cancers have prolonged progression-free survival, but these drugs are not curative and therefore are reserved for patients with progressive or symptomatic disease.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>27240885</pmid><doi>10.1016/S0140-6736(16)30172-6</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2016-12, Vol.388 (10061), p.2783-2795
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_miscellaneous_1826692040
source Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)
subjects Carcinoma, Neuroendocrine - diagnosis
Carcinoma, Neuroendocrine - diagnostic imaging
Carcinoma, Neuroendocrine - surgery
Clinical trials
Diagnosis, Differential
Disease-Free Survival
Humans
Internal Medicine
Iodine
Iodine radioisotopes
Kinases
Metastasis
Mutation
Severity of Illness Index
Thyroid
Thyroid cancer
Thyroid Neoplasms - diagnosis
Thyroid Neoplasms - diagnostic imaging
Thyroid Neoplasms - genetics
Thyroid Neoplasms - physiopathology
Thyroid Neoplasms - surgery
Tumors
title Thyroid cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T19%3A12%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Thyroid%20cancer&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Cabanillas,%20Maria%20E,%20Dr&rft.date=2016-12-03&rft.volume=388&rft.issue=10061&rft.spage=2783&rft.epage=2795&rft.pages=2783-2795&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(16)30172-6&rft_dat=%3Cproquest_cross%3E4272434411%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c547t-9856404f09559c57d3a7537aa8dcbdd48aa8aa5a692247d7b1ca66711ab74f3c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1846830258&rft_id=info:pmid/27240885&rfr_iscdi=true